pyogenic granulomas MedDRA version: 9.1 Level: LLT Classification code 10029539
Conditions
Interventions
Product Name: propranolol cream 1%
Pharmaceutical Form: Cream
INN or Proposed INN: Propranolol
Concentration unit: % percent
Concentration type: equal
Concentration number: 1-
Sponsors
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients > 4 weeks of age and Adult patients with pyogenic granuloma Pediatric Patients whose parents have signed a informed consent or adult patients who have signed an informed consent Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: - Hypersensitivity to propranolol in first degree relatives - Severe clinical conditions that contraindicate the inclusion in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: The aim of this study is to report the efficacy of the topical propranolol 1% in the treatment of pyogenic granulomas;Secondary Objective: the tollerability of the topical propranolol 1% in the treatment of pyogenic granulomas;Primary end point(s): the efficacy of the topical propranolol 1% in the treatment of pyogenic granulomas in the terms of reduction /dissappearing of the cutaneous lesion | — |
Countries
Italy
Outcome results
None listed